By Nick Johnson (Apyx) In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, RenuvionPosted January 13, 2025APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE RESULTS READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, RenuvionPosted January 6, 2025APYX MEDICAL CORPORATION SUBMITS 510(K) PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BODY CONTOURING SYSTEM™ READ MORE